No Data
NEP INTERLONG: 2024 INTERIM REPORT
NEP INTERLONG: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Nep Interlong (08329): Shenzhen Neptunus Bioengineering plans to change its equity structure.
NEP Interlong (08329) announced that the company has obtained a strategic investment from Shenzhen Neptunus Bioengineering Co., Ltd. (Neptunus Bioengineering)...
Neptune Interlon (08329) announced its first quarter results. Profit attributable to shareholders of 19.3 million yuan increased 18.67% year over year
Neptune Interlon (08329) announced the first quarter results for the three months ended March 31, 2024. The group took...
NEP INTERLONG: ABSTRACT OF THE FIRST QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2024
Neptune Interlon (08329.HK) will purchase medical devices from the Neptune Group
Gelonghui, May 7, 丨 Neptune Interlon (08329.HK) announced that the company and Neptune Biotech (the company's controlling shareholder and related party) entered into a 2024 framework agreement on May 7, 2024. Based on this, the Group will purchase medical devices from Haiwang Group to be sold on behalf of China.
No Data
No Data